ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9843
+0.0078 (0.80%)
Apr 28, 2025, 4:00 PM EDT - Market closed
ABVC BioPharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.25 | 0.06 | 0.09 | 5.83 | 4.27 | Upgrade
|
| Short-Term Investments | 0.06 | 0.08 | 0.08 | 0.11 | - | Upgrade
|
| Cash & Short-Term Investments | 0.31 | 0.14 | 0.16 | 5.94 | 4.27 | Upgrade
|
| Cash Growth | 124.51% | -13.41% | -97.29% | 38.93% | 2861.44% | Upgrade
|
| Accounts Receivable | - | 0.01 | 0.86 | 0.43 | 0.3 | Upgrade
|
| Other Receivables | - | - | - | - | 0.12 | Upgrade
|
| Receivables | 1.16 | 0.76 | 1.37 | 0.43 | 0.85 | Upgrade
|
| Inventory | - | - | - | 0.03 | - | Upgrade
|
| Prepaid Expenses | 0.1 | 0.1 | 0.15 | 0.53 | 0.17 | Upgrade
|
| Restricted Cash | 0.62 | 0.66 | 1.31 | 0.74 | 0.73 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.15 | Upgrade
|
| Total Current Assets | 2.18 | 1.66 | 2.99 | 7.65 | 6.17 | Upgrade
|
| Property, Plant & Equipment | 1.15 | 1.38 | 1.74 | 2 | 2.29 | Upgrade
|
| Long-Term Investments | 2.26 | 2.53 | 0.84 | 0.93 | 1.19 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 0.12 | 0.98 | 1.79 | Upgrade
|
| Other Long-Term Assets | 1.95 | 2.22 | 3.15 | 1.59 | 0.16 | Upgrade
|
| Total Assets | 7.54 | 7.78 | 9.58 | 13.7 | 11.61 | Upgrade
|
| Accounts Payable | - | - | - | - | 0.02 | Upgrade
|
| Accrued Expenses | 3.21 | 3.12 | 2.44 | 1.3 | 2.12 | Upgrade
|
| Short-Term Debt | 1.46 | 0.92 | 1.91 | 1.87 | 2.12 | Upgrade
|
| Current Portion of Long-Term Debt | 1.09 | 1.04 | 0.34 | - | 0.25 | Upgrade
|
| Current Portion of Leases | 0.4 | 0.4 | 0.37 | 0.35 | 0.32 | Upgrade
|
| Current Income Taxes Payable | - | 0.11 | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.08 | 0.08 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Other Current Liabilities | 0.31 | 0.43 | 0.47 | 0.17 | 0.01 | Upgrade
|
| Total Current Liabilities | 6.56 | 6.1 | 5.54 | 3.69 | 4.84 | Upgrade
|
| Long-Term Debt | - | - | - | - | 2.62 | Upgrade
|
| Long-Term Leases | 0.24 | 0.41 | 0.79 | 1.12 | 1.46 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Total Liabilities | 6.82 | 6.53 | 6.34 | 4.83 | 8.94 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.03 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 78.6 | 73.98 | 67.94 | 58.11 | 40.75 | Upgrade
|
| Retained Earnings | -68.95 | -64.05 | -54.9 | -38.48 | -25.64 | Upgrade
|
| Treasury Stock | -8.91 | -8.9 | -9.1 | -9.1 | -9.1 | Upgrade
|
| Comprehensive Income & Other | 0.48 | 0.52 | -0.84 | -1.72 | -2.6 | Upgrade
|
| Total Common Equity | 1.23 | 1.55 | 3.1 | 8.84 | 3.44 | Upgrade
|
| Minority Interest | -0.5 | -0.3 | 0.14 | 0.03 | -0.78 | Upgrade
|
| Shareholders' Equity | 0.72 | 1.25 | 3.24 | 8.87 | 2.66 | Upgrade
|
| Total Liabilities & Equity | 7.54 | 7.78 | 9.58 | 13.7 | 11.61 | Upgrade
|
| Total Debt | 3.2 | 2.77 | 3.41 | 3.34 | 6.76 | Upgrade
|
| Net Cash (Debt) | -2.88 | -2.63 | -3.25 | 2.6 | -2.49 | Upgrade
|
| Net Cash Per Share | -0.25 | -0.61 | -1.03 | 1.04 | -1.26 | Upgrade
|
| Filing Date Shares Outstanding | 15.05 | 10.53 | 3.28 | 3 | 2.41 | Upgrade
|
| Total Common Shares Outstanding | 13.14 | 7.91 | 3.26 | 2.87 | 2.41 | Upgrade
|
| Working Capital | -4.38 | -4.45 | -2.56 | 3.96 | 1.33 | Upgrade
|
| Book Value Per Share | 0.09 | 0.20 | 0.95 | 3.09 | 1.42 | Upgrade
|
| Tangible Book Value | 1.23 | 1.55 | 3.1 | 8.84 | 3.44 | Upgrade
|
| Tangible Book Value Per Share | 0.09 | 0.20 | 0.95 | 3.09 | 1.42 | Upgrade
|
| Land | 0.34 | 0.36 | 0.36 | 0.4 | 0.4 | Upgrade
|
| Buildings | 2.22 | 2.23 | 2.23 | 2.24 | 2.23 | Upgrade
|
| Machinery | 1.29 | 1.31 | 1.29 | 1.21 | 1.18 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.